By Chris Wack
Sonoma Pharmaceuticals Inc. and partner MicroSafe Group DMCC have received EPA approval for Nanocyn as a hospital-grade disinfectant in the US
Nanocyn, which is made by Sonoma, is a ready-to-use hard-surface disinfectant that may reduce the risk of infection, especially useful in high-risk areas such as hospitals, schools, mass transit, and care facilities.
Nanocyn hospital-grade disinfectant is sold by MicroSafe Group in Europe, the Middle East/West Africa and Australia.
In May 2020, Nanocyn was entered into the Australian Register of Therapeutic Goods for use against Covid-19.
The US Environmental Protection Agency approval process was coordinated by Sonoma and MicroSafe Group. MicroSafe Group managed and financed the regulatory process with the EPA in exchange for non-exclusive rights to distribute Nanocyn in the US Sonoma provided expertise and manufactured the required product samples.
Sonoma shares were up 18% to $3.11 in premarket trading.
Write to Chris Wack at [email protected]
,
Credit: www.marketwatch.com /